CVE:QPT Quest PharmaTech (QPT) Stock Price, News & Analysis C$0.03 -0.01 (-14.29%) As of 07/11/2025 11:43 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesInsider TradesBuy This Stock About Quest PharmaTech Stock (CVE:QPT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Quest PharmaTech alerts:Sign Up Key Stats Today's RangeC$0.03▼C$0.0350-Day RangeC$0.03▼C$0.0652-Week RangeC$0.02▼C$0.06Volume18,000 shsAverage Volume68,104 shsMarket CapitalizationC$5.07 millionP/E RatioN/ADividend Yield6.15%Price TargetN/AConsensus RatingN/A Company Overview Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada. Read More Receive QPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. Email Address QPT Stock News HeadlinesQuest PharmaTech Inc. (QPT.V) - Yahoo FinanceJuly 8, 2025 | ca.finance.yahoo.comQuest PharmaTech Inc. (QPTFF) - Yahoo FinanceJune 27, 2025 | au.finance.yahoo.comA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.July 12 at 2:00 AM | American Alternative (Ad)Quest PharmaTech Inc.: Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTechJune 11, 2025 | finanznachrichten.deQuest PharmaTech Strengthens Stake in Cancer ImmunotherapyJune 2, 2025 | tipranks.comQuest PharmaTech Provides Corporate UpdateJune 2, 2025 | financialpost.comFQPT:CA Quest PharmaTech Inc.May 29, 2025 | seekingalpha.comQuest PharmaTech Inc (QPT)November 1, 2024 | investing.comSee More Headlines QPT Stock Analysis - Frequently Asked Questions How have QPT shares performed this year? Quest PharmaTech's stock was trading at C$0.03 at the beginning of the year. Since then, QPT shares have increased by 0.0% and is now trading at C$0.03. How do I buy shares of Quest PharmaTech? Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Quest PharmaTech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quest PharmaTech investors own include Cameco (CCJ), Indiva (NDVA), Titan Medical (TMD), Aurinia Pharmaceuticals (AUP), Athenex (ATNX), Athersys (ATHX) and Antibe Therapeutics (ATE). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:QPT CIKN/A Webwww.questpharmatech.com Phone+1-780-4481400FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$2.88 million Net MarginsN/A Pretax MarginN/A Return on Equity-6.28% Return on Assets-1.07% Debt Debt-to-Equity Ratio4.35 Current Ratio0.40 Quick Ratio0.52 Sales & Book Value Annual SalesC$38.87 thousand Price / Sales130.53 Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueC$0.14 per share Price / Book0.21Miscellaneous Outstanding Shares169,130,000Free FloatN/AMarket CapC$5.07 million OptionableNot Optionable Beta0.14 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (CVE:QPT) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest PharmaTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest PharmaTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.